Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PCSK9 inhibitors
PCSK9 inhibitors
Despite Promising Early Data, The New Cholesterol Lowering Drug - PCSK9si - Has Significant Hurdles
Forbes
Thu, 10/20/16 - 09:12 am
PCSK9 inhibitors
PCSK9si
The Medicines Company
Amgen, Sanofi and Regeneron trot out new PCSK9 data at European heart meeting
Fierce Pharma
Mon, 08/29/16 - 05:52 pm
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Repatha
Praluent
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year
Motley Fool
Sun, 08/28/16 - 10:07 am
PCSK9 inhibitors
Amgen
Repatha
Regeneron
Praluent
Sanofi
Amgen refutes 'flawed' cholesterol study
BioPharma Dive
Mon, 08/22/16 - 10:06 pm
Amgen
PCSK9 inhibitors
JAMA
Repatha
Are PCSK9 meds worth the cost? Only if Amgen, Sanofi and Regeneron slash prices by two-thirds: JAMA
Fierce Pharma
Wed, 08/17/16 - 12:11 pm
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Praluent
Repatha
JAMA
drug pricing
Amgen touts new dosing option for underperforming cholesterol drug
BioPharma Dive
Wed, 07/13/16 - 04:04 pm
Amgen
Repatha
PCSK9 inhibitors
FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor
Yahoo
Mon, 07/11/16 - 10:53 am
FDA
Amgen
Repatha
Repatha Pushtronex
PCSK9 inhibitors
Pfizer, Amgen, Regeneron Pharmaceuticals: How the PCSK9 Market is Evolving
Bidness, ETC
Thu, 07/7/16 - 03:41 pm
Pfizer
Amgen
Regeneron
PCSK9 inhibitors
Repatha
Praluent
Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Yahoo
Tue, 07/5/16 - 10:10 am
Regeneron
Sanofi
Praluent
Japan
PCSK9 inhibitors
Pfizer's PCSK9 drug notches two Phase 3 wins
BioPharma Dive
Fri, 07/1/16 - 09:35 am
Pfizer
PCSK9 inhibitors
bococizumab
clinical trials
Pfizer's bococizumab may hit the PCSK9 market just in time
Fierce Pharma
Thu, 06/30/16 - 09:32 am
Pfizer
bococizumab
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Amgen, Inc. can Force Praluent Off Market but Regeneron Pharmaceuticals Inc May Still Be OK
Bidness, ETC
Thu, 06/16/16 - 03:22 pm
Amgen
Sanofi
Regeneron
Praluent
Repatha
patents
PCSK9 inhibitors
Cigna makes deals with Amgen, Sanofi for PCSK9 cholesterol drugs
Yahoo/Reuters
Wed, 05/11/16 - 11:22 am
Cigna
Amgen
Sanofi
Praulent
Repatha
PCSK9 inhibitors
Sanofi, Amgen cholesterol drugs win UK backing after price cuts
Yahoo/Reuters
Fri, 05/6/16 - 10:47 am
Sanofi
Amgen
UK
PCSK9 inhibitors
Repatha
Praluent
Amgen's PCSK9 patent win 'reasonably likely' to push Sanofi's Praluent off the market: Analyst
Fierce Pharma
Tue, 03/22/16 - 04:12 pm
Amgen
patents
Sanofi
PCSK9 inhibitors
Regeneron
Repatha
Praluent
Amgen Ahead of Regeneron; Controlling 60% of PCSK-9 Market
Bidness, ETC
Wed, 02/17/16 - 10:46 am
Amgen
Regeneron
Sanofi
PCSK9 inhibitors
Repatha
Praluent
Express Scripts sees slow 2016 sales for new cholesterol drugs
Yahoo/Reuters
Fri, 02/12/16 - 04:15 pm
Express Scripts
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Fierce Pharma Marketing
Wed, 02/10/16 - 03:20 pm
PCSK9 inhibitors
heart failure
Praluent
Repatha
Novartis
Amgen
Sanofi
Regeneron
Amgen Is Now Strides Ahead of Regeneron in the PCSK9 Race
Bidness, ETC
Tue, 02/9/16 - 04:26 pm
Amgen
Regeneron
PCSK9 inhibitors
Praluent
Repatha
Sanofi and Regeneron likely to cough up royalties to end Amgen's PCSK9 patent suit: Analyst
Fierce Pharma
Tue, 01/26/16 - 09:03 pm
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Repatha
Praluent
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »